Nectero Therapeutics
PrivateLast Round
Series D
Jan 18, 2024
Total Funding Raised
$115.5M
Company Overview
Nectero Therapeutics is a clinical-stage biotechnology company developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
aneurysm stabilizationabdominal aortic aneurysmAAAendovascular aneurysm stabilizationdrug-device combinationminimally invasive treatmentwatchful waiting alternativepentagalloyl glucosePGGendovascular systemvascular surgery deviceaortic wall strengtheningdual-balloon catheterclinical-stage biotechbreakthrough therapy designation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nectero Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Nectero Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 18, 2024 | ||||
| Series C | Sep 10, 2021 | ||||
| Series B | Apr 30, 2020 |
Nectero Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aphelion Capital | Series D |
| Cadence MedTech Ventures | Series D |
| Norwest Venture Partners | Series D |
| Boston Scientific Corporation | Series D, Series C |
| BioStar Capital | Series D |
Nectero Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nectero Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersTempe, Arizona
Year Founded2017
Last FundingJan 18, 2024
